Copyright Reports & Markets. All rights reserved.

Global Ophthalmic Anti-infective Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Ophthalmic Anti-infective Drug by Type
    • 1.3.1 Overview: Global Ophthalmic Anti-infective Drug Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Ophthalmic Anti-infective Drug Consumption Value Market Share by Type in 2024
    • 1.3.3 Eyedrops
    • 1.3.4 Gels
    • 1.3.5 Ointments
    • 1.3.6 Other
  • 1.4 Global Ophthalmic Anti-infective Drug Market by Application
    • 1.4.1 Overview: Global Ophthalmic Anti-infective Drug Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Others
  • 1.5 Global Ophthalmic Anti-infective Drug Market Size & Forecast
  • 1.6 Global Ophthalmic Anti-infective Drug Market Size and Forecast by Region
    • 1.6.1 Global Ophthalmic Anti-infective Drug Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Ophthalmic Anti-infective Drug Market Size by Region, (2020-2031)
    • 1.6.3 North America Ophthalmic Anti-infective Drug Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Ophthalmic Anti-infective Drug Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Ophthalmic Anti-infective Drug Market Size and Prospect (2020-2031)
    • 1.6.6 South America Ophthalmic Anti-infective Drug Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Ophthalmic Anti-infective Drug Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Alcon
    • 2.1.1 Alcon Details
    • 2.1.2 Alcon Major Business
    • 2.1.3 Alcon Ophthalmic Anti-infective Drug Product and Solutions
    • 2.1.4 Alcon Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Alcon Recent Developments and Future Plans
  • 2.2 AbbVie
    • 2.2.1 AbbVie Details
    • 2.2.2 AbbVie Major Business
    • 2.2.3 AbbVie Ophthalmic Anti-infective Drug Product and Solutions
    • 2.2.4 AbbVie Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 AbbVie Recent Developments and Future Plans
  • 2.3 Bausch Health
    • 2.3.1 Bausch Health Details
    • 2.3.2 Bausch Health Major Business
    • 2.3.3 Bausch Health Ophthalmic Anti-infective Drug Product and Solutions
    • 2.3.4 Bausch Health Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Bausch Health Recent Developments and Future Plans
  • 2.4 Santen Pharmaceutical
    • 2.4.1 Santen Pharmaceutical Details
    • 2.4.2 Santen Pharmaceutical Major Business
    • 2.4.3 Santen Pharmaceutical Ophthalmic Anti-infective Drug Product and Solutions
    • 2.4.4 Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Santen Pharmaceutical Recent Developments and Future Plans
  • 2.5 Lupin Pharmaceuticals
    • 2.5.1 Lupin Pharmaceuticals Details
    • 2.5.2 Lupin Pharmaceuticals Major Business
    • 2.5.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
    • 2.5.4 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Lupin Pharmaceuticals Recent Developments and Future Plans
  • 2.6 Apotex
    • 2.6.1 Apotex Details
    • 2.6.2 Apotex Major Business
    • 2.6.3 Apotex Ophthalmic Anti-infective Drug Product and Solutions
    • 2.6.4 Apotex Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Apotex Recent Developments and Future Plans
  • 2.7 Akorn
    • 2.7.1 Akorn Details
    • 2.7.2 Akorn Major Business
    • 2.7.3 Akorn Ophthalmic Anti-infective Drug Product and Solutions
    • 2.7.4 Akorn Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Akorn Recent Developments and Future Plans
  • 2.8 Johnson & Johnson
    • 2.8.1 Johnson & Johnson Details
    • 2.8.2 Johnson & Johnson Major Business
    • 2.8.3 Johnson & Johnson Ophthalmic Anti-infective Drug Product and Solutions
    • 2.8.4 Johnson & Johnson Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.9 Thea pharmaceuticals
    • 2.9.1 Thea pharmaceuticals Details
    • 2.9.2 Thea pharmaceuticals Major Business
    • 2.9.3 Thea pharmaceuticals Ophthalmic Anti-infective Drug Product and Solutions
    • 2.9.4 Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Thea pharmaceuticals Recent Developments and Future Plans
  • 2.10 URSAPHARM
    • 2.10.1 URSAPHARM Details
    • 2.10.2 URSAPHARM Major Business
    • 2.10.3 URSAPHARM Ophthalmic Anti-infective Drug Product and Solutions
    • 2.10.4 URSAPHARM Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 URSAPHARM Recent Developments and Future Plans
  • 2.11 SIMILASAN
    • 2.11.1 SIMILASAN Details
    • 2.11.2 SIMILASAN Major Business
    • 2.11.3 SIMILASAN Ophthalmic Anti-infective Drug Product and Solutions
    • 2.11.4 SIMILASAN Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 SIMILASAN Recent Developments and Future Plans
  • 2.12 Jianfeng Group
    • 2.12.1 Jianfeng Group Details
    • 2.12.2 Jianfeng Group Major Business
    • 2.12.3 Jianfeng Group Ophthalmic Anti-infective Drug Product and Solutions
    • 2.12.4 Jianfeng Group Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Jianfeng Group Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Ophthalmic Anti-infective Drug Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Ophthalmic Anti-infective Drug by Company Revenue
    • 3.2.2 Top 3 Ophthalmic Anti-infective Drug Players Market Share in 2024
    • 3.2.3 Top 6 Ophthalmic Anti-infective Drug Players Market Share in 2024
  • 3.3 Ophthalmic Anti-infective Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Ophthalmic Anti-infective Drug Market: Region Footprint
    • 3.3.2 Ophthalmic Anti-infective Drug Market: Company Product Type Footprint
    • 3.3.3 Ophthalmic Anti-infective Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Ophthalmic Anti-infective Drug Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Ophthalmic Anti-infective Drug Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Ophthalmic Anti-infective Drug Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Ophthalmic Anti-infective Drug Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Ophthalmic Anti-infective Drug Consumption Value by Type (2020-2031)
  • 6.2 North America Ophthalmic Anti-infective Drug Market Size by Application (2020-2031)
  • 6.3 North America Ophthalmic Anti-infective Drug Market Size by Country
    • 6.3.1 North America Ophthalmic Anti-infective Drug Consumption Value by Country (2020-2031)
    • 6.3.2 United States Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Ophthalmic Anti-infective Drug Consumption Value by Type (2020-2031)
  • 7.2 Europe Ophthalmic Anti-infective Drug Consumption Value by Application (2020-2031)
  • 7.3 Europe Ophthalmic Anti-infective Drug Market Size by Country
    • 7.3.1 Europe Ophthalmic Anti-infective Drug Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 7.3.3 France Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Ophthalmic Anti-infective Drug Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Ophthalmic Anti-infective Drug Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Ophthalmic Anti-infective Drug Market Size by Region
    • 8.3.1 Asia-Pacific Ophthalmic Anti-infective Drug Consumption Value by Region (2020-2031)
    • 8.3.2 China Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 8.3.5 India Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Ophthalmic Anti-infective Drug Consumption Value by Type (2020-2031)
  • 9.2 South America Ophthalmic Anti-infective Drug Consumption Value by Application (2020-2031)
  • 9.3 South America Ophthalmic Anti-infective Drug Market Size by Country
    • 9.3.1 South America Ophthalmic Anti-infective Drug Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Ophthalmic Anti-infective Drug Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Ophthalmic Anti-infective Drug Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Country
    • 10.3.1 Middle East & Africa Ophthalmic Anti-infective Drug Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Ophthalmic Anti-infective Drug Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Ophthalmic Anti-infective Drug Market Drivers
  • 11.2 Ophthalmic Anti-infective Drug Market Restraints
  • 11.3 Ophthalmic Anti-infective Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Ophthalmic Anti-infective Drug Industry Chain
  • 12.2 Ophthalmic Anti-infective Drug Upstream Analysis
  • 12.3 Ophthalmic Anti-infective Drug Midstream Analysis
  • 12.4 Ophthalmic Anti-infective Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ophthalmic Anti-infective Drug market size was valued at US$ 1614 million in 2024 and is forecast to a readjusted size of USD 2011 million by 2031 with a CAGR of 3.2% during review period.
    Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Ophthalmic Anti-infective Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ophthalmic Anti-infective Drug market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Ophthalmic Anti-infective Drug market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Ophthalmic Anti-infective Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Ophthalmic Anti-infective Drug market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ophthalmic Anti-infective Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ophthalmic Anti-infective Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alcon, AbbVie, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Johnson & Johnson, Thea pharmaceuticals, URSAPHARM, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Ophthalmic Anti-infective Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Eyedrops
    Gels
    Ointments
    Other
    Market segment by Application
    Hospital
    Retail Pharmacy
    Others
    Market segment by players, this report covers
    Alcon
    AbbVie
    Bausch Health
    Santen Pharmaceutical
    Lupin Pharmaceuticals
    Apotex
    Akorn
    Johnson & Johnson
    Thea pharmaceuticals
    URSAPHARM
    SIMILASAN
    Jianfeng Group
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Ophthalmic Anti-infective Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Ophthalmic Anti-infective Drug, with revenue, gross margin, and global market share of Ophthalmic Anti-infective Drug from 2020 to 2025.
    Chapter 3, the Ophthalmic Anti-infective Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Ophthalmic Anti-infective Drug market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Ophthalmic Anti-infective Drug.
    Chapter 13, to describe Ophthalmic Anti-infective Drug research findings and conclusion.

    Buy now